References
- Isbister G, Page C. Brown snake envenoming: why are we left in the dark? Clin Toxicol 2015.
- http://www.cochrane.org/about-us/evidence-based-health-care#REF1 Accessed 29 August 2015.
- Allen GE, Brown SGA, Buckley NA, O’Leary MA, Page CB, Currie BJ, White J, Isbister GK, ASP Investigators. Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming-Australian Snakebite Project (ASP-14). PLoS One 2012;7:e53188.
- Isbister GK, Duffull SB, Brown SGA. Failure of antivenom to improve recovery in Australian snakebite coagulopathy. Quarter J Med 2009;102:563–568.
- O’Leary MA, Maduwage K, Isbister GK. Detection of venom after administration is largely due to bound venom. Toxicon 2014;93:112–118.
- Viala VL, Hildebrand D, Trusch M, Fucase TM, Sciani JM, Pimenta DC, et al. Venomics of the Australian eastern brown snake (Pseudonaja textilis): detection of new venom proteins and splicing variants. Toxicon doi: http://dx.doi.org/10.1016/j.toxicon.2015.06.005.
- Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, Part I. Mayo Clin Proc 2009;84:917–938.
- Jayes Jr RL, Beshansky JR, D’Agostino RB, Selker HP. Do patients’ coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicentre study. J Clin Epidemiol 1992;45:621–626.
- Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Circulation 2012;126:2020–2035.
- Wenger NK. ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline): highlights for the clinician. Clin Cardiol 2012;35:3–8.
- Weinstein SA, White J, Ou J, Haiart S, Galluccio S. Errata to: “An instructive case of presumed brown snake (Pseudonaja spp.) envenoming”, Judy Ou, Sebastien Haiart, Steven Galluccio, Julian White, Scott A. Weinstein. Clin Toxicol 2015;53:834–839.